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Summary
Introduction:  Resection  margins  constitute  a  recognized  risk  factor  for  local  recurrence,  but
their impact  on  survival  is  less  clear.
Hypothesis:  Inﬁltrative  proliferation  and  satellite  nodules  are  prognostic  factors  for  local  and
systemic aggressiveness.
Type  of  study:  Retrospective  cohort  study.
Patients  and  methods:  In  105  patients  under  curative  treatment,  resection  quality  was  assessed
on UICC  criteria  (R0/R1)  and  on  a  modiﬁed  version  (R0  M/R1  M)  taking  account  of  proliferation
contours and  satellite  nodules  for  narrow  margins  (<  1  mm).  Uni-  and  multi-variate  analysis  was
performed,  and  Kaplan-Meier  survival  curves  were  compared  on  log-rank.
Results:  Mean  5-year  local  recurrence-free  survival  (LRFS)  was  0.64  [0.52—0.76]  after  R1
surgery, 0.9  [0.85—0.95]  after  R0,  0.64  [0.519—0.751]  after  R1  M  and  0.92  [0.87—0.96]  after
R0 M.  Resection  type  according  to  R  classiﬁcation  correlated  with  disease-free  survival  (DFS)
(P =  0.028),  but  not  with  metastasis-free  survival  (MFS)  (P  =  0.156).  Resection  type  according
to RM  classiﬁcation  correlated  with  DFS  and  MFS.  Multivariate  analysis  disclosed  correlations
between LRFS  rate  and  RM  resection  type  (HR  6.77  [1.78—25.7],  P  =  0.005),  DFS  rate  and  RM
resection  type  (HR  2.83  [1.47—5.43],  P  =  0.001)  and  grade  (HR  =  3.17  [1.38—7.27],  P  =  0.003),
and MFS  and  grade  (HR  =  3.96  [1.50—10.5],  P  =  0.006).
Discussion:  The  microscopic  aspect  of  the  proliferation  contours  and  presence  of  satellite  nod-
ules were  conﬁrmed  as  prognostic  factors  for  local  and  systemic  aggressiveness.  They  impact
both disease-free  survival  and  metastasis-free  survival  in  case  of  margins  less  than  1  mm.  Their
systematic  consideration  may  help  identify  patients  with  elevated  systemic  risk.
Level of  evidence:  IV.
© 2012  Elsevier  Masson  SAS.  All  
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oft-tissue  sarcoma  (STS)  is  rarely  encountered  in  everyday
ractice  (incidence,  0.75—1/100,000  per  year)  [1],  and  has  a
served.
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ortality  rate  of  50%.  Surgery  tends  to  be  mutilating.  Treat-
ent  should  follow  guidelines  and  standards  to  optimize
rognosis  [1,2]. The  current  trend  is  in  favor  of  reference
enters  [3—5]  with  appropriate  diagnostic  and  therapeutic
ethodology  and  multidisciplinary  expertise  [6—8].
Treatment  is  based  on  adequate  surgical  resection  [9],
adiation  therapy  [5,10]  and  chemotherapy  [11,12],  either
ystemic  or  by  isolated  perfusion  of  the  affected  limb
13].  Following  Simon  and  Enneking  [9,14], limb-conserving
urgery  has  become  the  gold  standard.  To  achieve  resection
argins  as  close  to  the  tumor  as  possible,  assessment  of
esection  quality  has  become  a  critical  factor  in  diagnosis
nd  prognosis.
Resection  margins  [7,9,15—23]  represent  the  main  risk
actor  for  local  recurrence.  Tumor  grade  [19,20,24,25]  and
ize  [15,19,20,24,25]  correlate  with  overall  survival.  Depth
1,19,20]  and  histologic  type  [18,26]  have  also  been  consi-
ered,  but  with  poor  agreement  between  reports  as  to  their
mpact  on  local  recurrence,  overall  survival  or  both  [19,20].
ocal  recurrence,  however,  appears  as  a  negative  factor  in
verall  survival  [25]. Moreover,  one-third  of  high-grade  STSs
how  recurrence  despite  satisfactory  local  control  [12].
Many  prognostic  classiﬁcations  have  been  published  by
uthoritative  bodies:  Union  for  International  Cancer  Control
UICC),  Fédération  nationale  des  centres  de  lutte  contre  le
ancer  (FNCLCC),  JOA  and  SIN  (Table  1).
The  French  FNCLCC  consensus  system  [27,28]  is  based  on
he  UICC  classiﬁcation  [29]: macroscopic  residuals  (R2),  pos-
ible  microscopic  residuals  (R1),  and  in  sano  resection  (R0).
he  data  are  assessed  in  the  multidisciplinart  team  meet-
ng,  where  a  treatment  program  is  drawn  up;  Stoeckle  et  al.
emonstrated  the  usefulness  of  this  approach  [6,7]. The
apanese  classiﬁcation  [26]  is  likewise  based  on  resection
argins  [14,30],  adapted  according  to  histotype,  surroun-
ing  tissue,  chemotherapy  and  primitive  or  recurrent  tumor
tatus.  Engellau  recommends  a  system  [12]  also  taking
ccount  of  tumor  proliferation  contours  [31], categorized  as
‘inﬁltrating’’  (poorly  deﬁned  contours)  or  ‘‘pushing’’  (well
eﬁned  contours)  (Fig.  1).
The  present  working  hypothesis  is  that,  in  narrow  margins
<  1  mm),  proliferation  contours  and  satellite  nodules  impact
ocal  recurrence  risk  and  overall  disease-free  survival.
A  single-center  retrospective  study  recruited  105
atients  who  had  undergone  surgery  with  curative  intent.
esection  margins  were  classiﬁed  using  the  FNCLCC  system
‘‘R’’)  and  on  a  modiﬁed  system  (‘‘RM’’)  taking  prolifera-
ion  contours  and  satellite  nodules  into  account  in  case  of
arrow  margins.
atients and methods
he  study  initially  recruited  a  consecutive  series  of
89  patients  operated  on  with  curative  intent  between
anuary  2000  and  January  2007.  Data  were  collected  ret-
ospectively  by  an  independent  investigator.  The  last
ollow-up  date  was  January  2010;  median  FU  was  42  months
interquartile  range,  24—60  months).  There  was  no  loss  to
ollow-up.
Inclusion  criteria  were  referral  for  soft-tissue  sarcoma  of
he  extremities  or  trunk  and  treatment  with  curative  intent.
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Figure  1  A.  Well-contoured  proliferation.  B.  Poorly-contoured  proliferation.  C.  Well-contoured  proliferation:  aponeurotic  plane,
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(ﬁbrous pseudocapsule  and  adipose  tissue  plane:  grade  III  mali
contoured inﬁltrative,  invasive  proliferation:  grade  I  myxoﬁbros
Eighty-four  patients  were  excluded  on  the  ﬂowing  crite-
ria:
•  low-grade  ‘‘lipoma-like’’  liposarcoma  (47  patients);
•  non-respect  of  the  French  Sarcoma  Group  (Groupe  sar-
come  franc¸ais) Standards,  Options  and  Recommendations
[32,33]  (24  patients);
•  palliative  surgery  (scheduled  R2)  (13  patients).
The  study  series  thus  comprised  105  patients.  Median  age
was  59  years  (14—88);  58  male,  47  female  (sex-ratio  1.2:1).
Mean  tumor  size  was  8  cm  (1—25  cm).  In  84  cases  (80%),
lesions  were  located  in  the  lower  limbs  or  pelvic  belt,  65  in
the  thigh  or  buttocks,  and  19  in  the  leg  or  foot.  Twenty
(19%)  were  in  the  upper  limbs  or  scapular  belt,  13  in  the
arms  or  shoulders,  and  7  in  the  forearms  or  hands.  In  one
t
e
it  histiocytoﬁbroma-like  pleomorphic  sarcoma.  D.  Very  poorly
ma.
ase,  the  location  was  in  the  trunk.  Tumors  were  primitive
n  84  cases  (80%)  and  recurrent  in  21  (20%).  Twenty-six  (25%)
ere  superﬁcial  or  supra-aponeurotic,  and  79  (75%)  deep  or
ub-aponeurotic  (Table  2).  ).
In  line  with  the  literature  [34], malignant  ﬁbrous  histio-
ytoma,  undifferentiated  sarcoma  and  pleomorphic  sarcoma
ere  grouped  together,  and  represented  the  most  frequent
istologic  type  (50  cases:  48%),  followed  by  leiomyosarcoma
12  cases,  11%)  and  synovial  sarcoma  (ten  cases,  10%).  His-
ologic  grading  was  on  the  FNCLCC  classiﬁcation  [27,28]:
9  tumors  (56%)  were  grade  III,  29  (28%)  grade  II  and  eight
8%)  grade  I.The  following  microscopic  characteristics  were  studied:
hickness  of  the  thinnest  margin  (distance  between  the  out-
rmost  tumor  cells  and  the  resection  line,  inked  with  India
nk),  classiﬁcation  of  tumor  proliferation  contours  according
S12  F.  Lintz  et  al.
Table  2  Characteristics  of  study  population.
Demographics  of  patients  and  tumors
Characteristics  N  %
Total 105  100
Age, years
Median 59 56
Interquartile  range 47—71
Gender
Female  47  45
Male 58  55
Location
Upper limb  20  19
Trunk 1  1
Lower limb  84  80
Size, cm
Median  8
Interquartile  range  5—12
Depth
Superﬁcial  26  25
Deep 79  75
Presentation
Primitive  84  80
Recurrent  21  20
Neoadjuvant  treatment
Radiation  therapy 5  5
Chemotherapy 16 15
Histologic  type
HFM 50 48
Leiomyosarcoma 12 11
Synovial  sarcoma 10 10
Myxoid  +Round-cell  Liposarcoma  9  9
Rhabdomyosarcoma  5  5
Other 19  18
FNCLCC  grade
I  8  8
II 29  28
III 59  56
Missing data  9  9
Margin characteristics
Characteristics  N  %
Total  105  100
Contours
Poorly contoured  36  34
Well contoured  59  56
Missing data  10  10
Table  2  (  Continued  ).
Margins
Intra-lesional  21  20
<1 mm  51  49
1—2 mm  17  16
>2 mm  13  12
Missing data  3  3
Satellite  nodules
Present 24 23
Absent  or  not  seen 81 77
Residual  disease  R  (FNCLCC)
R0 75  71
R1 30  29
Residual  disease  RM  (Modiﬁed  FNCLCC)
R0  M  65  62
R1 M  40  38
Type of  exeresis
Compartmental  43  41
Extra-compartmental  62  59
Macroscopic  resection
Wide  56  53
Marginal  46  44
Missing data  3  3
Peroperative  capsule  rupture
t
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wContaminated  5  5
Non-contaminated  100  95
o  Mandard  et  al.  [31]  and  presence  of  satellite  nodules.  Mar-
ins  were  intra-lesional  in  20  cases  (19%),  less  than  1  mm  in
1  (49%)  and  greater  than  1  mm  in  30  (28%).  Proliferation  was
oorly  contoured  in  36  cases  (34%)  and  well-contoured  in  59
56%).  Non-available  data  were  censured.  Resection  quality
as  assessed  following  the  Union  for  International  Cancer
ontrol  (UICC)  [29], as  recommended  by  the  FNCLCC  [6]:
0  resections  were  graded  R1  (29%)  and  75  (71%)  R0.
Margins  were  re-classiﬁed  on  the  ‘‘Modiﬁed  R’’  system
Table  3):  resection  in  greater  or  equal  to  1  mm  healthy
argin  was  still  graded  R0  M,  whatever  the  type  of  prolife-
ation;  margins  less  than  1  mm  or  in  contact  with  the  tumor
ere  graded  R0  M  in  case  of  well-contoured  proliferation
Table  3  Principles  of  the  ‘‘Modiﬁed  R’’  (RM)  classiﬁcation
for residual  disease  risk.
Minimum  thinnest
margin  thickness
Proliferation  contours
and  satellite  nodules
RM  Status
≥  1  mm  ROM
< 1  mm  or  in  contact  Nodules  absent,
well-contoured
R0  M
< 1  mm  or  in  contact Poorly  contoured
and/or  nodules
present
R1  M
Analysis  of  soft-tissue  sarcoma  resection  margins  S13
Figure  2  Classiﬁcation  of  tumor  proliferation  contours.  A.  Margin  less  than  1  mm,  well-contoured  proliferation:  R0M  (grade  II
myxoﬁbrosarcoma).  B.  Margin  less  than  1  mm,  poorly-contoured  proliferation:  R1M  (grade  III  myxoid  pleomorphic  sarcoma).
S F.  Lintz  et  al.
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Figure  3  Estimated  raw  cumulative  incidence  of  local  recur-
rence (LR)  on  Kaplan-Meier  method  on  the  RM  (modiﬁed
FNCLCC)  classiﬁcation  (log-rank:  P  <  0.001).
Figure  4  Estimated  raw  cumulative  incidence  of  local  recur-
rence (LR)  on  Kaplan-Meier  method  on  the  RM  (modiﬁed
FNCLCC)  classiﬁcation  (log-rank:  P  <  0.03).
(
M
r
[
a
c
C
m14  
nd  absence  of  satellite  nodules,  and  R1  M  in  case  of  poorly
ontoured  proliferation  and/or  presence  of  satellite  nodules
Fig.  2  ).
Macroscopic  resection  was  classiﬁed  as  marginal
46  cases,  44%)  or  wide  (56  cases,  53%),  following  Enneking
14,30].  In  ﬁve  cases,  tumor  capsule  rupture  was  found
eroperatively,  and  surgery  was  classiﬁed  as  contaminated;
 standardized  procedure  was  then  implemented  [35]: the
upture  was  sutured,  the  instruments  were  withdrawn,
he  affected  region  was  irrigated  and  suspect  areas  were
esected.
The  entire  specimen  was  inked  with  India  ink  before
ormaldehyde  ﬁxation.
Adjuvant  radiation  therapy  was  used  in  high-grade
umors  with  insufﬁcient  resection  margins.  Neoadjuvant
nthracycline-based  chemotherapy  was  applied  in  16  high-
rade  tumors,  based  on  histology:  synovial  sarcoma,
habdomyosarcoma,  soft-tissue  osteosarcoma,  Ewing  sar-
oma,  angiosarcoma  or  undifferentiated  sarcoma.  There
ere,  however,  no  prospective  decision  criteria  laid  down:
he  decision  was  made  according  to  individual  risk,  in  the
ultidisciplinary  team  meeting.
Statistical  analysis  used  SPSS® software  for  Windows®
SPSS  version  17.0,  SPSS  Inc.,  Chicago,  IL,  USA).
The  assessment  criteria  were:  local  recurrence-free  sur-
ival  (LRFS),  metastasis-free  survival  (MFS)  and  disease-free
urvival  (DFS).  Time  to  event  occurrence  was  measured  from
ate  of  surgery  to  date  of  event  diagnosis  (or  last  follow-up
n  case  of  censure).
Risk  factors  were  explored  on  univariate  analysis.
ichotic  variables  were  compared  on  log-rank  test,  and  con-
inuous  variables  on  the  Cox  model.
Multivariate  analysis  was  applied  to  the  most  informa-
ive  variables  (P  <  0.2).  Adjusted  hazard  ratios  and  95%
onﬁdence  intervals  were  derived  from  the  estimated
oefﬁcients.  P-values  <  5%  were  considered  statistically  sig-
iﬁcant.
Survival  was  analyzed  on  Kaplan-Meier  curves.  Distribu-
ions  were  compared  on  log-rank  test.
esults
n  the  series  as  a  whole,  LRFS  was  0.87  [0.83—0.91)  at  5  years
nd  0.80  [0.73—0.87]  at  10  years;  DFS  was  0.78  [0.73—0.83]
t  5  years  and  0.59  [0.45—0.73]  at  10  years;  MFS  was  0.90
0.86—0.94]  at  5  years  and  0.76  [0.66—0.86]  at  10  years.
ocal  recurrence-free  survival  (LRFS)
ocal  recurrence  was  diagnosed  in  21  of  the  105  patients
20%).  On  univariate  analysis  (Table  4),  inﬁltrative  or  poorly
ontoured  proliferation  (HR  4.37,  [1.27—15.01],  P  =  0.02),
eroperative  contamination  (HR  0.03,  [0.00—0.32],
 <  0.004),  R1  surgery  (HR  3.61,  [1.1—11.86],  P  =  0.005)
nd  R1  M  surgery  (HR  6.89,  [1.82—26.13],  P  =  0.035)  were
igniﬁcantly  associated  with  risk  of  local  recurrence
5
[
ﬁ
g
. Margin less than 1 mm, well contoured: ROM (grade 1 myxoﬁbrosarc
yxoﬁbrosarcoma). E. Intralesional resection: R1M (grade III myxoid andFigs.  3  and  4).  On  multivariate  analysis  (Table  5),  only  R1
 surgery  was  signiﬁcantly  associated  with  risk  of  local
ecurrence  (adjusted  HR  =  6.77,  [1.78—25.7],  P  =  0.005).
On  log-rank  test,  estimated  5-year  LRFS  was  0.64
0.52—0.76]  following  R1  surgery,  versus  0.90  [0.85—0.94]
fter  R0  (P  =  0.023).  The  RM  classiﬁcation  was  more  dis-
riminative  and  showed  greater  signiﬁcance:  estimated
-year  LRFS  0.63  [0.52—0.75]  after  R1  M  surgery  and  0.92
0.87—0.96]  after  R0  M  (P  =  0.001).  Other  variables  signi-
cantly  associated  with  local  recurrence  risk  were  tumor
rade  (P  =  0.03)  and  poorly  contoured  tumor  (P  =  0.01).oma). D. Margin less than 1 mm, poorly contoured: R1M (grade II
 pleomorphic sarcoma).
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Table  4  Univariate  analysis.
Univariate  analysis  of  factors  for  local  recurrence-free  survival  (LRFS)  (P-value  and  95%  conﬁdence  interval)
Characteristics  (Reference)  Hazard  Ratio  95%  CI  P
Demography
Gender  (male)  1.63  0.48—5.56  0.439
Age (>  60  years)  1.03  0.99—1.06  0.124
Neoadjuvanrt  chemotherapy  (received) 0.55  0.07—4.32  0.571
Presentation  (recurrence) 2.1 0.61—7.22  0.239
Size (>  8  cm) 1.07 0.98—1.18  0.138
Tumor
Location (Thigh) 1.24 0.38—4.06  0.726
Depth(Sub-aponeurotic) 0.98 0.26—3.70  0.975
Grade (3) 4.59  0.99—21.34  0.052
Proliferation  contours  (poorly  contoured)  4.37  1.27—15.01  0.019
Satellite  nodules  (present)  3.11  0.90—10.68  0.072
Surgery
Type (extra-compartmental) 0.67 0.20—2.19  0.505
Peroperative  contamination  (non-contaminated) 0.03 0.00—0.32  0.004
Macroscopic  resection  type  (marginal) 3.69 0.97—13.97  0.055
Thinnest margin  thickness  (<  1  mm) 4.96 0.63—39.00  0.128
RM (R1  M) 6.89 1.82—26.13  0.005
R  (R1) 3.61 1.10—11.86  0.035
Univariate  analysis  of  factors  for  disease-free  survival  (DFS)  (P-value  and  95%  conﬁdence  interval)
Characteristics  (Reference)  Hazard  Ratio  95%  CI  P
Demography
Gender  (male)  1.28  0.69—2.37  0.440
Age (>  60  years)  1.02  1.00—1.04  0.033
Neoadjuvanrt  chemotherapy  (received)  1.25  0.58—2.71  0.569
Presentation  (recurrence)  1.27  0.63—2.60  0.504
Size (>  8  cm)  1.04  0.99—1.10  0.140
Tumor
Location (Thigh) 1.11  0.60—2.04  0.739
Depth (Sub-aponeurotic) 1.14 0.56—2.31  0.727
Grade (3) 3.73 1.64—8.47  0.002
Proliferation  contours  (poorly  contoured) 2.56 1.34—4.88  0.004
Satellite  nodules  (present)  2.07  1.10—3.91  0.024
Surgery
Type  (extra-compartmental)  1.37  0.72—2.60  0.339
Peroperative  contamination  (non-contaminated)  2.57  0.99—6.61  0.051
Macroscopic  resection  type  (marginal)  1.85  0.97—3.51  0.061
Thinnest margin  thickness  (<  1  mm)  2.09  0.93—4.72  0.076
RM (R1  M)  3.05  1.64—5.66  ≤0,001
R  (R1)  1.94  1.05—3.59  0.033
Univariate analysis  of  factors  for  metastasis-free  survival  (MFS)  (P-value  and  95%  conﬁdence  interval)
Characteristics  (Reference)  Hazard  Ratio  95%  CI  P
Demography
Gender  (male)  1.21  0.59—2.47  0.607
Age (>  60  years)  1.02  0.99—1.04  0.065
Neoadjuvanrt  chemotherapy  (received)  1.55  0.67—3.61  0.306
Presentation  (recurrence)  1.00  0.41—2.43  0.991
Size (>  8  cm)  1.03  0.97—1.10  0.364
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Table  4  (  Continued  ).
Characteristics  (Reference) Hazard  Ratio  95%  CI  P
Tumor
Location (Thigh)  1.11  0.55—2.26  0.766
Depth (Sub-aponeurotic)  1.21  0.52—2.83  0.651
Grade (3) 3.83  1.45—10.12  0.007
Proliferation  contours  (poorly  contoured) 2.34 1.09—5.04  0.028
Satellite  nodules  (present) 2.05 0.98—2.48  0.991
Surgery
Type (extra-compartmental) 1.98 0.88—4.43  0.097
Peroperative  contamination  (non-contaminated)  2.74  0.94—7.97  0.064
Macroscopic  resection  type  (marginal)  1.60  0.76—3.35  0.215
Thinnest margin  thickness  (<  1  mm)  1.73  0.71—4.24  0.228
RM (R1  M)  2.55  1.25—5.20  0,010
R  (R1)  1.67  0.81—3.45  0,164
Data in bold: values of P < 0.2 in univariate analysis, used in multivariate analysis. Underlined data: values of P < 0.05 or statistically
signiﬁcant in univariate analysis.
Table  5  Signiﬁcant  variables  in  Cox  multivariate  models
(P-value  and  95%  conﬁdence  interval).
Outcome  Risk  factor  HR  95%  CI  P
Local
recurrence
R1  M  6.77  1.78—25.7  0.005
Metastasis  Grade  3  3.96  1.5—10.5  0.006
Disease-free R1 M  3.18  1.60—6.32  0.001
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Grade  3  4.27  1.65—11.2  0.003
isease-free  survival  (DFS)
t  last  follow-up,  60  patients  (59%)  showed  no  diagnosed
ocal  recurrence  or  metastasis.  On  univariate  analysis,
rade-3  tumor  (HR  =  3.73  [1.64—8.47],  P  =  0.002),  poorly
ontoured  proliferation  (HR  =  2.56  [1.34—4.88],  P  =  0.004),
1  surgery  (HR  =  1.94  [1.05—3.59],  P  =  0.033),  R1  M  surgery
HR  =  3.05  [1.64—5.66],  P  <  0.001)  and  satellite  nodules
HR  =  2.07  [1.10—3.91],  P  =  0.024)  were  negatively  associ-
ted  with  DFS.  On  multivariate  analysis,  grade-3  tumor
adjusted  HR  =  4.27  [1.65—11.2],  P  =  0  .003)  and  R1  M  surgery
adjusted  HR  =  3.18  [1.60—6.32],  P  =  0.001)  were  associated.
On  log-rank  test,  estimated  5-year  DFS  was  0.694
0.628—0.760]  for  R0  M  surgery  and  0.317  [0.228—0.406]
or  R1  M  (P  <  0.001).  On  the  R  classiﬁcation,  estimated  5-
ear  DFS  was  0.638  [0.574—0.702]  for  R0  surgery  and  0.356
0.256—0.456]  for  R1  (P  =  0.028).  Other  variables  signiﬁ-
antly  associated  with  DFS  were  poorly  contoured  margins
P  =  0.003),  grade-3  tumor  (P  =  0.001)  and  satellite  nodules
P  =  0.019).
etastasis-free  survival  (MFS)
t  last  follow-up,  71  patients  (70%)  were  free  of  metas-
asis.  On  univariate  analysis,  grade-3  tumor  (HR  =  3.83
1.45—10.1],  P  =  0.007),  poorly  contoured  margins  (HR  =  2.34
1.09—5.04],  P  =  0.028)  and  R1  M  surgery  (HR  =  2.55
1.25—5.20],  P  =  0.01)  were  signiﬁcantly  associated  with
n
R
higure  5  Estimated  raw  cumulative  incidence  of  metastasis
Kaplan-Meier  method)  according  to  Grade  (log-rank  P  <  0.003).
ccurrence  of  metastasis  and  death(Figs.  5  and  6).  On
ultivariate  analysis,  grade-3  tumor  (adjusted  HR  =  3.96
1.50—10.5],  P  =  0.006)  was  associated  with  MFS.
On  log-rank  test,  estimated  5-year  MFS  was  0.751
0.689—0.813]  for  R0  M  surgery  and  0.425  [0.317—0.533]
or  R1  M  (P  = 0.007).  5-year  MFS  did  not  signiﬁcantly  differ
P  =  0.156)  between  R0  (0.70  [0.64—0.76]  and  R1  surgery
0.48  [0.36—0.60]).  Other  variables  signiﬁcantly  associated
ith  MFS  were  poorly  contoured  margins  (P  =  0.023),  grade-3
umor  (P  =  0.003)  and  satellite  nodules  (P  =  0.05).
iscussion
he  most  important  ﬁnding  of  the  present  study  is  that,  in
ase  of  narrow  (<  1  mm)  resection  margins,  poorly  contoured
icroscopic  proliferation  and  presence  of  satellite  nodules
hould  be  taken  into  account  in  order  to  improve  the  prog-
ostic  analysis  of  residual  disease  provided  by  the  FNCLCC
 system.
This  original  study  in  105  patients  sheds  new  light  on
ow  surgery  quality  in  adult  soft-tissue  sarcoma  impacts
Analysis  of  soft-tissue  sarcoma  resection  margins  
Figure  6  Estimated  raw  cumulative  incidence  of  metas-
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overall  survival  as  well  as  local  control.  The  strong  points
are  the  single-center  design  in  a  sarcoma  reference  center,
with  uniﬁed  management  by  a  specialized  team  following
FNCLCC  guidelines,  thus  avoiding  bias  inherent  to  divergent,
multicenter  management.  Moreover,  low-grade  lipoma-like
liposarcomas  were  excluded,  which  in  other  studies  intro-
duced  bias  due  to  their  very  different  management  and
evolution,  closer  to  those  of  locally  or  locoregionally  aggres-
sive  lesions  [36]: they  were  identiﬁed  by  Gerrand  et  al.
[18]  as  a  group  with  low  evolutivity  in  which  marginal  or
intralesional  focal  resection  may  be  sufﬁcient  [37].
The  weak  points  of  the  study  lie  in  the  relatively  small
series  compared  to  other  reports  [5,19,20,22,24,38], due  to
a  shorter  inclusion  period  with  stricter  exclusion  criteria.
Another  limitation  was  that  certain  data  were  missing,  so
that  the  corresponding  patients  were  counted  as  censured
in  statistical  analysis.
The  present  series  was  similar  to  others  in  terms  of
general  demographic  characteristics.  The  median  age  was
59  years,  compared  to  50  for  Gronchi  et  al.  [19]  and  65  for
the  Scandinavian  Sarcoma  Group  (SSG)  [2].  The  initial  series
included  30%  low-grade  liposarcoma,  compared  to  31%  for
Gronchi  et  al.  [19]  and  14%  for  the  SSG  [2].  Mean  tumor
size  was  8  cm,  compared  to  6  cm  for  Gronchi  et  al.  [19]  and
7  cm  for  the  SSG  [2].  The  rate  of  inadequate  surgery  (R1  for
scheduled  R0  on  the  UICC  system,  validated  by  the  FNCLCC)
was  29%,  comparable  to  the  26.5%  rate  in  the  most  recent
report  (Stoeckle  et  al.  [7]).  The  5-year  LRFS  rate  of  90%  in
adequate  surgery  (FNCLCC  R0)  was  comparable  to  that  of
Stoeckle  (93%),  who  did  not  exclude  low-grade  liposarcoma.
Stoeckle’s  study,  published  in  2006,  was  a  prospective
evaluation  of  the  FNCLCC’s  consensus  prognosis  system
[2,7,19].  It  demonstrated  better  discrimination  for  this  mul-
tidisciplinary  resection  margin-based  approach,  with  4-fold
elevated  risk  of  type-R1  resection  [7].  The  method  is,  how-
ever,  still  based  on  the  UICC  system,  in  which  R1  is  rather
vaguely  deﬁned  by  potential  microscopic  tumor  residue,
liable  to  be  interpreted  differently  from  team  to  team.  In
our  own  experience,  margins  less  than  1  mm  are  harder  to
interpret.  This  is  borne  out  by  studies  [19,39]  in  which  the
minimal  positive  margin  was  deﬁned  by  thickness,  required
to  be  greater  or  equal  to  1  mm.  Sadoski  et  al.  [39]  reported
[S17
ittle  beneﬁt  (3%)  in  local  control  with  margins  exceeding
 mm.  The  risk  of  residual  disease  is  harder  to  assess  micro-
copically,  especially  where  the  proliferation  area  is  poorly
ontoured  or  where  satellite  nodules  are  present.  To  get
round  this,  we  re-classiﬁed  resection  with  poorly  contoured
umor  and/or  satellite  nodules  as  ‘‘R1M’’,  and  as  ‘‘R0M’’
hose  in  which  the  tumor  is  well-contoured  and  there  are  no
atellite  nodules.
The  present  modiﬁed  UICC  system  ﬁnds  support  with  Man-
ard  et  al.  [31], who  reported  unfavorable  prognosis  for  DFS
nd  MFS  in  case  of  ‘‘invasive’’  resection  margins.  Engellau
12,40]  distinguished  ‘‘inﬁltrative’’  and  ‘‘pushing’’  margins,
hich  he  included  in  a  prognostic  algorithm  which  improved
he  performance  of  the  Scandinavian  SIN  system.  This  was
ounded  on  his  studies  [17,40,41]  of  the  Tissue  Micro  Array
TMA)  technique,  demonstrating  the  interest  of  Ki-67  protein
nd  its  independent  prognostic  value  for  metastasis.
These  ﬁndings  suggest  that  tumor  proliferation  type  rep-
esents  not  only  a  technical  problem  for  surgeons,  increasing
he  risk  of  intralesional  resection  and  microscopic  residue,
ut  also  a  marker  of  systemic  aggressiveness.
In  conclusion,  the  present  proposed  modiﬁcations  in
argin  classiﬁcation  (RM)  could  enable  more  reproductible
escription  of  less  than  1  mm  margins  and  also,  along
ith  other  known  factors  (histological  grading,  size,  sub-
poneurotic  nature),  help  identify  not  only  patients  at  risk  of
ocal  recurrence  but  also  those  with  poorer  survival  chances.
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